[Administration of clarithromycin (CAM) to non-small cell lung cancer]

Jpn J Antibiot. 2000 Jan:53 Suppl A:52-5.
[Article in Japanese]
No abstract available

MeSH terms

  • Adenocarcinoma / drug therapy
  • Aged
  • Animals
  • Anti-Bacterial Agents / pharmacology
  • Anti-Bacterial Agents / therapeutic use*
  • Carcinoma, Non-Small-Cell Lung / drug therapy*
  • Carcinoma, Non-Small-Cell Lung / immunology
  • Carcinoma, Squamous Cell / drug therapy
  • Clarithromycin / pharmacology
  • Clarithromycin / therapeutic use*
  • Disease Models, Animal
  • Female
  • Humans
  • Immunologic Factors / pharmacology
  • Immunologic Factors / therapeutic use*
  • Interferon-gamma / metabolism
  • Interleukin-10 / metabolism
  • Interleukin-12 / metabolism
  • Lung Neoplasms / drug therapy*
  • Lung Neoplasms / immunology
  • Male
  • Mice
  • Mice, Inbred C57BL

Substances

  • Anti-Bacterial Agents
  • Immunologic Factors
  • Interleukin-10
  • Interleukin-12
  • Interferon-gamma
  • Clarithromycin